img

Global Glucagon Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glucagon Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
Glucagon Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glucagon Drug market is projected to reach US$ 5306.7 million in 2029, increasing from US$ 3652 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Emergency Kits and General Use are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucagon Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Segment by Type
Inject Glucagon
Nasal Glucagon

Segment by Application


Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glucagon Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glucagon Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glucagon Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glucagon Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glucagon Drug introduction, etc. Glucagon Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glucagon Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Glucagon Drug Market Overview
1.1 Glucagon Drug Product Overview
1.2 Glucagon Drug Market Segment by Type
1.2.1 Inject Glucagon
1.2.2 Nasal Glucagon
1.3 Global Glucagon Drug Market Size by Type
1.3.1 Global Glucagon Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Glucagon Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glucagon Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glucagon Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glucagon Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glucagon Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glucagon Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glucagon Drug Sales Breakdown by Type (2018-2024)
2 Global Glucagon Drug Market Competition by Company
2.1 Global Top Players by Glucagon Drug Sales (2018-2024)
2.2 Global Top Players by Glucagon Drug Revenue (2018-2024)
2.3 Global Top Players by Glucagon Drug Price (2018-2024)
2.4 Global Top Manufacturers Glucagon Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glucagon Drug Market Competitive Situation and Trends
2.5.1 Glucagon Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glucagon Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Glucagon Drug Market
2.8 Key Manufacturers Glucagon Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glucagon Drug Status and Outlook by Region
3.1 Global Glucagon Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Glucagon Drug Historic Market Size by Region
3.2.1 Global Glucagon Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Glucagon Drug Sales in Value by Region (2018-2024)
3.2.3 Global Glucagon Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glucagon Drug Forecasted Market Size by Region
3.3.1 Global Glucagon Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Glucagon Drug Sales in Value by Region (2024-2029)
3.3.3 Global Glucagon Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Glucagon Drug by Application
4.1 Glucagon Drug Market Segment by Application
4.1.1 Emergency Kits
4.1.2 General Use
4.1.3 Diagnostic & Motility
4.1.4 Cardiogenic Shock
4.1.5 Others
4.2 Global Glucagon Drug Market Size by Application
4.2.1 Global Glucagon Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Glucagon Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glucagon Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glucagon Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glucagon Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glucagon Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glucagon Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glucagon Drug Sales Breakdown by Application (2018-2024)
5 North America Glucagon Drug by Country
5.1 North America Glucagon Drug Historic Market Size by Country
5.1.1 North America Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Glucagon Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Glucagon Drug Sales in Value by Country (2018-2024)
5.2 North America Glucagon Drug Forecasted Market Size by Country
5.2.1 North America Glucagon Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Glucagon Drug Sales in Value by Country (2024-2029)
6 Europe Glucagon Drug by Country
6.1 Europe Glucagon Drug Historic Market Size by Country
6.1.1 Europe Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Glucagon Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Glucagon Drug Sales in Value by Country (2018-2024)
6.2 Europe Glucagon Drug Forecasted Market Size by Country
6.2.1 Europe Glucagon Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Glucagon Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Glucagon Drug by Region
7.1 Asia-Pacific Glucagon Drug Historic Market Size by Region
7.1.1 Asia-Pacific Glucagon Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Glucagon Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glucagon Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glucagon Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Glucagon Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Glucagon Drug Sales in Value by Region (2024-2029)
8 Latin America Glucagon Drug by Country
8.1 Latin America Glucagon Drug Historic Market Size by Country
8.1.1 Latin America Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Glucagon Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glucagon Drug Sales in Value by Country (2018-2024)
8.2 Latin America Glucagon Drug Forecasted Market Size by Country
8.2.1 Latin America Glucagon Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Glucagon Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Glucagon Drug by Country
9.1 Middle East and Africa Glucagon Drug Historic Market Size by Country
9.1.1 Middle East and Africa Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Glucagon Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glucagon Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glucagon Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Glucagon Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Glucagon Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Glucagon Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novo Nordisk Glucagon Drug Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Glucagon Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Eli Lilly Glucagon Drug Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Fresenius Kabi Glucagon Drug Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Torrent Labs
10.4.1 Torrent Labs Company Information
10.4.2 Torrent Labs Introduction and Business Overview
10.4.3 Torrent Labs Glucagon Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Torrent Labs Glucagon Drug Products Offered
10.4.5 Torrent Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glucagon Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glucagon Drug Industrial Chain Analysis
11.4 Glucagon Drug Market Dynamics
11.4.1 Glucagon Drug Industry Trends
11.4.2 Glucagon Drug Market Drivers
11.4.3 Glucagon Drug Market Challenges
11.4.4 Glucagon Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glucagon Drug Distributors
12.3 Glucagon Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inject Glucagon
Table 2. Major Company of Nasal Glucagon
Table 3. Global Glucagon Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Glucagon Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Glucagon Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Glucagon Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Glucagon Drug Market Share in Value by Type (2018-2024)
Table 8. Global Glucagon Drug Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Glucagon Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Glucagon Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Glucagon Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Glucagon Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Glucagon Drug Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Glucagon Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Glucagon Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Glucagon Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Glucagon Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Glucagon Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Glucagon Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Glucagon Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Glucagon Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Glucagon Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Glucagon Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Glucagon Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Glucagon Drug Sales Share by Company (2018-2024)
Table 26. Global Glucagon Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Glucagon Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Glucagon Drug Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Glucagon Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Glucagon Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Glucagon Drug Market
Table 33. Key Manufacturers Glucagon Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Glucagon Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Glucagon Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Glucagon Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Glucagon Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Glucagon Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Glucagon Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Glucagon Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Glucagon Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Glucagon Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Glucagon Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Glucagon Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Glucagon Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Glucagon Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Glucagon Drug Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Glucagon Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Glucagon Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Glucagon Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Glucagon Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Glucagon Drug Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Glucagon Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Glucagon Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Glucagon Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Glucagon Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Glucagon Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Glucagon Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Glucagon Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Glucagon Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Glucagon Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Glucagon Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Glucagon Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Glucagon Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Glucagon Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Glucagon Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Glucagon Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Glucagon Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Glucagon Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Glucagon Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Glucagon Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Glucagon Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Glucagon Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Glucagon Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Glucagon Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Glucagon Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Glucagon Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Glucagon Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Glucagon Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Glucagon Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Glucagon Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Glucagon Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Glucagon Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Glucagon Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Glucagon Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Glucagon Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Glucagon Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Glucagon Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Glucagon Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Glucagon Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Glucagon Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Glucagon Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Glucagon Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Glucagon Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Glucagon Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Glucagon Drug Sales Market Share in Value by Country (2024-2029)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Introduction and Business Overview
Table 109. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Novo Nordisk Glucagon Drug Product
Table 111. Novo Nordisk Recent Development
Table 112. Eli Lilly Company Information
Table 113. Eli Lilly Introduction and Business Overview
Table 114. Eli Lilly Glucagon Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Eli Lilly Glucagon Drug Product
Table 116. Eli Lilly Recent Development
Table 117. Fresenius Kabi Company Information
Table 118. Fresenius Kabi Introduction and Business Overview
Table 119. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Fresenius Kabi Glucagon Drug Product
Table 121. Fresenius Kabi Recent Development
Table 122. Torrent Labs Company Information
Table 123. Torrent Labs Introduction and Business Overview
Table 124. Torrent Labs Glucagon Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Torrent Labs Glucagon Drug Product
Table 126. Torrent Labs Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Glucagon Drug Market Trends
Table 130. Glucagon Drug Market Drivers
Table 131. Glucagon Drug Market Challenges
Table 132. Glucagon Drug Market Restraints
Table 133. Glucagon Drug Distributors List
Table 134. Glucagon Drug Downstream Customers
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Drug Product Picture
Figure 2. Global Glucagon Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Glucagon Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Glucagon Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Inject Glucagon
Figure 6. Global Inject Glucagon Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Nasal Glucagon
Figure 8. Global Nasal Glucagon Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Glucagon Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Glucagon Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Glucagon Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Glucagon Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Glucagon Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Glucagon Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Glucagon Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Glucagon Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Glucagon Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Glucagon Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Glucagon Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Drug Revenue in 2022
Figure 23. Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Emergency Kits
Figure 25. Global Emergency Kits Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of General Use
Figure 27. Global General Use Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Diagnostic & Motility
Figure 29. Global Diagnostic & Motility Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Cardiogenic Shock
Figure 31. Global Cardiogenic Shock Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Glucagon Drug Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Glucagon Drug Sales Market Share by Application in 2022 & 2029
Figure 36. North America Glucagon Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Glucagon Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Glucagon Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Glucagon Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Glucagon Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Glucagon Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Glucagon Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Glucagon Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Glucagon Drug Manufacturing Cost Structure
Figure 47. Glucagon Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed